This inventor holds 1 USPTO granted patent. Top assignee: Intrexon Corporation. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Charles E Reed: Innovator in Therapeutic Inhibitors
Introduction
Charles E Reed is a notable inventor based in Souderton, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic inhibitors. His work focuses on polynucleotides that encode ligands and modulators of PAI-1, which have implications for treating various medical conditions.
Latest Patents
Charles E Reed holds 1 patent for his invention titled "Polynucleotides encoding therapeutic inhibitors of PAI-1." This invention relates to mammalian PAI-1 ligands and modulators. It encompasses polypeptides, polypeptide compositions, and polynucleotides that encode polypeptides acting as ligands and/or modulators of PAI-1. The invention also includes polyligands that can modulate PAI-1 activity, as well as localization tethers and promoter sequences for spatial control of these ligands. Additionally, it discusses inducible gene switches for temporal control and methods for treating or preventing atherosclerosis and fibrosis.
Career Highlights
Charles E Reed is associated with Intrexon Corporation, where he continues to advance his research and innovations. His work has contributed to the understanding and potential treatment of conditions related to PAI-1.
Collaborations
Throughout his career, Charles has collaborated with notable colleagues, including Thomas David Reed and Richard E Peterson. These collaborations have likely enhanced the scope and impact of his research.
Conclusion
Charles E Reed is a prominent inventor whose work on therapeutic inhibitors has the potential to significantly impact medical treatments. His innovative approach to PAI-1 modulation showcases the importance of biotechnology in addressing health challenges.